Abstract:In the present study, a new series of 1,2,4-triazole linked pyrazole hybrids (5 a-5 l) were synthesized from dimethyl amino pyrazole (1) in good yield by three-step reaction. The chemical structures of the resulted compounds were thoroughly elucidated using spectral analyses such as IR, 1H-NMR, 13C-NMR, mass spectra and elemental analysis. The target compounds were screened for their antimicrobial activity against the various standard pathogenic Gram-(-ve) (E. coli, P. aeruginosa, K. pneumoniae, A. baumannii), and Gram-(+ve) (S. aureus, S. faecalis) microorganisms. According to the results obtained, in particular, compounds 5 b, 5 f, 5 h and 5 j was effective at inhibiting the antibacterial growth of all the bacteria's, having MIC values ranging 0.983-14.862 mg/mL and compared to moxifloxacin (1.391-22.01 mg mL-1). The most active compounds were chosen to interact with the DNA gyrase and topoisomerase-IV targets via molecular docking. These selected ligands interacted with 2XCO, 1S16 targets and docked into the active site of amino acids Ala-269, Gly-413, Asn-405, Ser-1182, Thr-1185, His-1186, His-1186, Lys-1189, and Trp-1213. Computational studies were carried out to design the precursor compounds to support the experimental part of the study. The pharmacokinetic properties, stability, and drug-likeness parameters of all target molecules were estimated using SwissADME and PkCSM protocols. The current study used in silico approaches combining e-pharmacophore modeling and structure-based molecular docking of targets to identify antimicrobial agents.

Metronidazole Containing Pyrazole Derivatives Potently Inhibit Tyrosyl-Trna Synthetase: Design, Synthesis, and Biological Evaluation

Novel Potentially Antibacterial Naphthalimide-Derived Metronidazoles: Design, Synthesis, Biological Evaluation and Supramolecular Interactions with DNA, Human Serum Albumin and Topoisomerase II

Synthesis and Evaluation of New Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents Based on a N2-(arylacetyl)glycinanilide Scaffold

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, Synthesis and Molecular Docking of Salicylic Acid Derivatives Containing Metronidazole As a New Class of Antimicrobial Agents

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

4-Alkoxy-3-arylfuran-2(5h)-ones As Inhibitors of Tyrosyl-Trna Synthetase: Synthesis, Molecular Docking and Antibacterial Evaluation.

4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5h)-one As Inhibitors of Tyrosyl-Trna Synthase: Synthesis, Molecular Docking and Antibacterial Evaluation

3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.

Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents: Synthesis, Molecular Docking and Structure-Activity Relationship Analysis of 3-Aryl-4-arylaminofuran-2(5h)-ones

Synthesis, Molecular Docking and Biological Evaluation of Metronidazole Derivatives Containing Piperazine Skeleton As Potential Antibacterial Agents

Adenosine Analogs As Inhibitors of Tyrosyl-Trna Synthetase: Design, Synthesis and Antibacterial Evaluation.

C-7 modified flavonoids as novel tyrosyl-tRNA synthetase inhibitors

Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.

Tyrosyl-tRNA synthetase inhibitors: a patent review

Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B

Synthesis and Evaluation of Adenosine Containing 3-Arylfuran-2(5h)-ones As Tyrosyl-Trna Synthetase Inhibitors

Exploring The Antimicrobial Potential of Novel 1,2,4-Triazole Conjugates with Pyrazole: Synthesis, Biological Activity and In Silico Docking

Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.

Metronidazole Acid Acyl Sulfonamide: A Novel Class of Anticancer Agents and Potential EGFR Tyrosine Kinase Inhibitors

Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.